BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 25989497)

  • 1. Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption.
    Becker LE; Siebert D; Süsal C; Opelz G; Leo A; Waldherr R; Macher-Goeppinger S; Schemmer P; Schaefer SM; Klein K; Beimler J; Zeier M; Schwenger V; Morath C
    Transplantation; 2015 Nov; 99(11):2364-71. PubMed ID: 25989497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation.
    Lee EC; Kim SH; Shim JR; Park SJ
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):119-125. PubMed ID: 29576278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
    Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
    Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M;
    Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of tandem hemodialysis and immunoadsorption to desensitize kidney transplant candidates.
    Rostaing L; Maggioni S; Hecht C; Hermelin M; Faudel E; Kamar N; Sallusto F; Doumerc N; Allal A
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():165-9. PubMed ID: 25894148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies.
    Masutani K; Tsuchimoto A; Kurihara K; Okabe Y; Kitada H; Okumi M; Tanabe K; Nakamura M; Kitazono T; Tsuruya K;
    Transplantation; 2017 Jun; 101(6):1416-1422. PubMed ID: 27391195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients.
    Sharif A; Alachkar N; Bagnasco S; Geetha D; Gupta G; Womer K; Arend L; Racusen L; Montgomery R; Kraus E
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1320-7. PubMed ID: 22626962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
    Kauke T; Klimaschewski S; Schoenermarck U; Fischereder M; Dick A; Guba M; Stangl M; Werner J; Meiser B; Habicht A
    PLoS One; 2016; 11(1):e0146075. PubMed ID: 26730981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Desensitization Allows Pediatric Blood Group Incompatible Kidney Transplantation.
    Stojanovic J; Adamusiak A; Kessaris N; Chandak P; Ahmed Z; Sebire NJ; Walsh G; Jones HE; Marks SD; Mamode N
    Transplantation; 2017 Jun; 101(6):1242-1246. PubMed ID: 27463537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent immunosuppression for ABO-incompatible renal transplantation may not be a risk factor for malignancy.
    Yamamoto T; Kawaguchi T; Watarai Y; Tujita M; Hiramitsu T; Nanmoku K; Goto N; Katayama A; Kobayashi T; Uchida K
    Transplant Proc; 2012 Jan; 44(1):210-3. PubMed ID: 22310616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of isoagglutinin titre with the current desensitization protocol in ABO-incompatible kidney transplantation.
    Baek CH; Kim H; Yang WS; Han DJ; Park SK
    Nephrology (Carlton); 2019 Jun; 24(6):654-660. PubMed ID: 29877001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
    Han S; Hwang E; Park S; Park U; Kim H; Cho W
    Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO-incompatible kidney transplantation enabled by non-antigen-specific immunoadsorption.
    Morath C; Becker LE; Leo A; Beimler J; Klein K; Seckinger J; Kihm LP; Schemmer P; Macher-Goeppinger S; Wahrmann M; Böhmig GA; Opelz G; Süsal C; Zeier M; Schwenger V
    Transplantation; 2012 Apr; 93(8):827-34. PubMed ID: 22382504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization with antigen-specific immunoadsorption interferes with complement in ABO-incompatible kidney transplantation.
    Biglarnia AR; Nilsson B; Nilsson Ekdahl K; Tufveson G; Nilsson T; Larsson E; Wadström J
    Transplantation; 2012 Jan; 93(1):87-92. PubMed ID: 22113493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in ABO-incompatible kidney transplantation.
    Aikawa A; Saito K; Takahashi K
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():18-22. PubMed ID: 25894122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of pediatric ABO-incompatible kidney transplantations are equivalent to ABO-compatible controls.
    Shishido S; Hyodo YY; Aoki Y; Takasu J; Kawamura T; Sakai KK; Aikawa AA; Satou H; Muramatsu MM; Matsui Z
    Transplant Proc; 2012 Jan; 44(1):214-6. PubMed ID: 22310617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of isoagglutinin titer in ABO-incompatible kidney transplantation.
    Won D; Choe W; Kim HJ; Kwon SW; Han DJ; Park SK
    J Clin Apher; 2014 Oct; 29(5):243-50. PubMed ID: 24375675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO-incompatible kidney transplantation: first cases in Turkey.
    Tuncer M; Yücetin L; Tekin S; Demirbas A
    Transplant Proc; 2012; 44(6):1703-5. PubMed ID: 22841248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent outcomes of ABO-incompatible kidney transplantation: a single-center experience.
    Uchida J; Kuwabara N; Machida Y; Iwai T; Naganuma T; Kumada N; Nakatani T
    Transplant Proc; 2012 Jan; 44(1):204-9. PubMed ID: 22310615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO desensitization affects cellular immunity and infection control after renal transplantation.
    Schachtner T; Stein M; Reinke P
    Transpl Int; 2015 Oct; 28(10):1179-94. PubMed ID: 26033637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.